APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $274,130 | -95.0% | 4,156 | -96.1% | 0.00% | -95.0% |
Q4 2022 | $5,470,091 | -44.1% | 105,784 | -26.2% | 0.02% | -55.6% |
Q3 2022 | $9,793,000 | +820.4% | 143,385 | +509.5% | 0.04% | +800.0% |
Q2 2022 | $1,064,000 | -67.2% | 23,525 | -63.2% | 0.01% | -54.5% |
Q1 2022 | $3,244,000 | +322.4% | 63,852 | +174.0% | 0.01% | +266.7% |
Q3 2021 | $768,000 | -86.4% | 23,300 | -73.9% | 0.00% | -85.0% |
Q2 2021 | $5,652,000 | -28.8% | 89,425 | -51.7% | 0.02% | -42.9% |
Q1 2021 | $7,942,000 | -37.2% | 185,074 | -16.3% | 0.04% | -37.5% |
Q4 2020 | $12,653,000 | +69.2% | 221,200 | -10.8% | 0.06% | +93.1% |
Q3 2020 | $7,479,000 | -11.0% | 247,886 | -3.7% | 0.03% | -31.0% |
Q2 2020 | $8,405,000 | +2322.2% | 257,346 | +1885.4% | 0.04% | +2000.0% |
Q1 2020 | $347,000 | – | 12,962 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |